Mental Disorders Overlap in Genetic Etiology

Genome-wide datasets reveal varying degrees of genetic similarity among five common psychiatric illnesses.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, CHRISTOPH BOCKFive psychiatric disorders, whose diagnoses are based on symptoms rather than biology, share a considerable number of genetic risk factors, researchers reported in Nature Genetics last week (August 11). Schizophrenia, bipolar disorder, and major depressive disorder have the greatest commonality among one another, while depression and attention-deficit/hyperactivity disorder (ADHD) share some genetic underpinnings, as do autism spectrum disorders (ASD) and schizophrenia. “Our results will likely contribute to the efforts now under way to base psychiatric nosology on a firmer empirical footing,” the researchers wrote in their report.

A massive international group of researchers, led by Kenneth Kendler at Virginia Commonwealth University and Naomi Wray at the University of Queensland in Australia, looked across thousands of single nucleotide polymorphisms (SNPs) among people with mental disorders. They found that genetic variants explained 17 percent to 28 percent of the risk for the illnesses. The overlap for this heritability was the highest between schizophrenia and bipolar disorder—15 percent. Together, these disorders shared 9 percent to 10 percent of the variants with depression, while schizophrenia and autism shared 3 percent.

The team found no relationships between ADHD and schizophrenia, bipolar disorder, or autism, nor between autism and bipolar disorder. In a press release, Wray said that she expects the genetic overlap among the conditions is actually ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies